-
Mashup Score: 0
A cross-sectional survey of patient preferences found that the out-of-pocket cost of treatment was the most impactful attribute for patients when choosing an androgen deprivation therapy (ADTs) for their prostate cancer.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
The risk of death from cardiovascular disease was elevated regardless of the duration of androgen deprivation therapy.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 12
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0JNCCN 360 - Prostate - SARS-CoV-2 and Prostate Cancer: Is ADT Protective Against Infection? - 3 year(s) ago
By: Kelly M. Hennessey, PhD Posted: Thursday, October 29, 2020 The focus of androgen-deprivation therapy (ADT) in the treatment of prostate cancer is the downregulation of the transmembrane protease, serine 2 (TMPRSS2) gene, which is upregulated in response to androgens in prostate cells. SARS-CoV-2 requires…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 10
Although our analysis lacked statistical power, we found no benefit for event-free survival in patients assigned to adjuvant radiotherapy compared with patients assigned to salvage radiotherapy. Adjuvant radiotherapy increased the risk of genitourinary toxicity and erectile dysfunction. A policy of early salvage radiotherapy could spare men from overtreatment with radiotherapy and the associated…
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
AbstractIntroduction:Patients with prostate cancer on androgen deprivation therapy are at increased risk for iatrogenic osteoporosis, minimal trauma fractures and reduced bone density. We created a…
Source: www.auajournals.orgCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 4
AbstractIntroduction:Patients with prostate cancer on androgen deprivation therapy are at increased risk for iatrogenic osteoporosis, minimal trauma fractures and reduced bone density. We created a…
Source: www.auajournals.orgCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0
AbstractIntroduction:Patients with prostate cancer on androgen deprivation therapy are at increased risk for iatrogenic osteoporosis, minimal trauma fractures and reduced bone density. We created a…
Source: www.auajournals.orgCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0
AbstractIntroduction:Patients with prostate cancer on androgen deprivation therapy are at increased risk for iatrogenic osteoporosis, minimal trauma fractures and reduced bone density. We created a…
Source: www.auajournals.orgCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1
The 120-month progression-free survival confirmed the results from the primary analysis. Salvage radiotherapy combined with short-term androgen suppression significantly reduced risk of biochemical or clinical progression and death compared with salvage radiotherapy alone. The results of the GETUG-AFU 16 trial confirm the efficacy of androgen suppression plus radiotherapy as salvage treatment in…
Source: The Lancet OncologyCategories: Hem/Onc News and JournalsTweet
A cross-sectional survey of patient preferences found that the #out-of-pocket cost of treatment was the most impactful attribute for patients when choosing an #AndrogenDeprivationTherapy (ADTs) for their #ProstateCancer. Learn more! https://t.co/pcwYZFpE9o https://t.co/uMjYxlZYIx